Oral peptides carry a practical safety advantage: they are easier to stop, and less likely to introduce complications tied to injections
All products sold by Aion Limitless are research compounds intended strictly for laboratory and in-vitro research use
Recombinant human growth hormone (rhGH) therapy has been introduced as a treatment for a variety of conditions associated with short stature, such as GH deficiency [19], Turner syndrome [20], chronic renal failure [21], short stature homeobox gene [22, 23], and Noonan syndrome [24]
Linear Angiotensin IV Analogues and Incorporation of Unnatural Amino Acids After systematic structure activity studies (SAR) of Ang IV analogues, involving glycine and D-amino acid scans in combination with displacement and incorporation of various alternative amino acid residues it became clear that the N-terminal Val-Tyr-Ile residues of the peptide ligands were important for high affinity to the specific binding site identified (Sardinia et al., 1993), named the AT4 receptor (de Gasparo et al., 1995)